Submitted by Anonymous (not verified) on 23 April 2026 - 16:02
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 12, Status: Authorised